At Mishkind Kulwicki Law, we frequently review, investigate and handle cases involving a failure to diagnose, prevent and/or treat pulmonary embolism. Blood clots can form in a variety of areas of the body and frequently occur after a surgical procedure or when a patient is on bed rest and not walking for an extended period of time. Conventional treatment has included heparin and coumadin to prevent the formation of blood clots and to treat blood clots when they are diagnosed before they embolize or travel to the lungs.
Now, a new and potentially safer method of treatment has been introduced. See the report in the New England Journal of Medicine at http://www.nejm.org/doi/full/10.1056/NEJMoa1113572
This medication, rivaroxaban, has been used to treat atrial fibrillation in the prevention of strokes and after knee and hip surgery. While it is not approved for the treatment of deep vein thrombosis or pulmonary embolism in the U.S., it is approved for the prevention of DVT formation. For more information on this topic visit our medical resource center.